Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -437.15% is 89% below its 5-year average of -230.75%, near the low end of its 5-year range (-559.13%–79.54%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.96% below its 12-month average of -266.63%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -437.15%.
RETURN ON EQUITY (ROE)
-437.15%
RETURN ON EQUITY (ROE) AVG TTM
-266.63%
RETURN ON EQUITY (ROE) AVG 3Y
-311.56%
RETURN ON EQUITY (ROE) AVG 5Y
-230.75%
RETURN ON EQUITY (ROE) AVG 10Y
-156.90%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-63.96%
CURRENT VS 3Y AVG
-40.31%
CURRENT VS 5Y AVG
-89.44%
CURRENT VS 10Y AVG
-178.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-940.58%
vs the sector median at left
Aptevo Therapeutics Inc.
Market Cap
$3.97M
Return on Equity (ROE)
-437.15%
TTM Avg
-266.63%
3Y Avg
-311.56%
5Y Avg
-230.75%
Market Cap
$3.85M
Return on Equity (ROE)
-310.33%
TTM Avg
-204.84%
3Y Avg
-115.20%
5Y Avg
-69.88%
Market Cap
$4.11M
Return on Equity (ROE)
N/A
TTM Avg
-470.92%
3Y Avg
-382.96%
5Y Avg
-276.61%
Market Cap
$4.13M
Return on Equity (ROE)
N/A
TTM Avg
-201.28%
3Y Avg
-1309.54%
5Y Avg
-838.52%
Market Cap
$3.62M
Return on Equity (ROE)
N/A
TTM Avg
5741.84%
3Y Avg
2797.55%
5Y Avg
1847.94%
Market Cap
$3.74M
Return on Equity (ROE)
-282.13%
TTM Avg
-313.25%
3Y Avg
-153.55%
5Y Avg
-153.55%
Market Cap
$3.61M
Return on Equity (ROE)
-383.03%
TTM Avg
-1602.50%
3Y Avg
-1094.59%
5Y Avg
-783.90%
Market Cap
$4.27M
Return on Equity (ROE)
-424.89%
TTM Avg
-156.14%
3Y Avg
-97.37%
5Y Avg
-86.32%
Market Cap
$4.44M
Return on Equity (ROE)
-184.04%
TTM Avg
9542.92%
3Y Avg
4740.03%
5Y Avg
3155.09%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.97M | -437.15% | -266.63% | -311.56% | -230.75% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.85M | -310.33% | -204.84% | -115.20% | -69.88% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | N/A | -470.92% | -382.96% | -276.61% |
| GRI Bio, Inc. (GRI)vs › | $4.13M | N/A | -201.28% | -1309.54% | -838.52% |
| Evogene Ltd. (EVGN)vs › | $3.62M | N/A | 5741.84% | 2797.55% | 1847.94% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.74M | -282.13% | -313.25% | -153.55% | -153.55% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.61M | -383.03% | -1602.50% | -1094.59% | -783.90% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.27M | -424.89% | -156.14% | -97.37% | -86.32% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.44M | -184.04% | 9542.92% | 4740.03% | 3155.09% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.58M | -5.85% | -5.85% | -10.40% | 7.36% |
ROE
-437.1%
ROA
-181.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -437.15% |
| 2026-03-31 | -226.11% |
| 2025-12-31 | -149.40% |
| 2025-09-30 | -152.21% |
| 2025-06-30 | -368.26% |
| 2024-12-31 | -507.47% |
| 2024-09-30 | -536.67% |
| 2024-06-30 | -559.13% |
| 2024-03-31 | -442.72% |
| 2023-12-31 | -142.48% |
| 2023-09-30 | -109.74% |
| 2023-06-30 | -107.43% |
| 2023-03-31 | 79.54% |
| 2022-12-31 | 44.66% |
| 2022-09-30 | 40.58% |
| 2022-06-30 | 30.56% |
| 2021-09-30 | -400.96% |
| 2021-06-30 | -209.15% |
| 2021-03-31 | -265.64% |
| 2020-12-31 | -106.97% |
| 2020-09-30 | -856.99% |
| 2020-06-30 | -219.70% |
| 2020-03-31 | -168.51% |
| 2019-12-31 | -341.56% |
| 2019-09-30 | -235.01% |
| 2019-06-30 | -198.63% |
| 2019-03-31 | -132.51% |
| 2018-12-31 | -176.57% |
| 2018-09-30 | -112.09% |
| 2018-06-30 | 1.98% |
| 2018-03-31 | 4.48% |
| 2017-12-31 | 8.50% |
| 2017-09-30 | 1.98% |
| 2017-06-30 | -209.69% |
| 2017-03-31 | -178.04% |
| 2016-12-31 | -220.22% |
| 2016-09-30 | -179.30% |
| 2016-06-30 | -56.84% |
| 2016-03-31 | -50.59% |
| 2015-12-31 | -66.93% |
